These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35145342)

  • 1. Patterns of adverse drug reactions (ADRs) in Saudi Arabia.
    Bin Yousef N; Yenugadhati N; Alqahtani N; Alshahrani A; Alshahrani M; Al Jeraisy M; Badri M
    Saudi Pharm J; 2022 Jan; 30(1):8-13. PubMed ID: 35145342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A National Survey of Community Pharmacists' Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia.
    Alsheikh MY; Alasmari MM
    Front Pharmacol; 2022; 13():819551. PubMed ID: 35721182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evaluation of adverse drug reactions in Saudi Arabia: A retrospective observational study.
    Alenzi KA; Alanazi NS; Almalki M; Alomrani H; Alatawi FO
    Saudi Pharm J; 2022 Jun; 30(6):735-741. PubMed ID: 35812140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
    Sales I; Aljadhey H; Albogami Y; Mahmoud MA
    Saudi Pharm J; 2017 Sep; 25(6):868-872. PubMed ID: 28951672
    [No Abstract]   [Full Text] [Related]  

  • 7. National Cross-Sectional Study of Community-Based Adverse Drug Reactions in Saudi Arabia.
    Almubark RA; Aljadani RH; Alqahtani AS; Alshammari TM; BinDhim NF
    Drugs Real World Outcomes; 2020 Jun; 7(2):161-170. PubMed ID: 32215839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 9. Consumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006.
    Aagaard L; Nielsen LH; Hansen EH
    Drug Saf; 2009; 32(11):1067-74. PubMed ID: 19810778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.
    Abu Esba LC; Al Mardawi G; AlJasser MI; Aljohani B; Abu Alburak A
    J Clin Pharm Ther; 2021 Apr; 46(2):460-469. PubMed ID: 33285001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia.
    Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM
    Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.
    Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E
    Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
    Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
    Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
    Aagaard L; Weber CB; Hansen EH
    Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.
    Aljadhey H; Mahmoud MA; Alshammari TM; Al-Dhaeefi M; Le Louet H; Perez-Gutthann S; Pitts PJ
    Saudi Med J; 2015 Sep; 36(9):1097-102. PubMed ID: 26318468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions reported by consumers for nervous system medications in Europe 2007 to 2011.
    Aagaard L; Hansen EH
    BMC Pharmacol Toxicol; 2013 Jun; 14():30. PubMed ID: 23763896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.